Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Berman

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 22, 2023
New Meningoencephalocele and Skull Base Changes Revealed by Trigeminal Neuralgia 14 Years After Diagnosis of Idiopathic Intracranial HypertensionGabriele Berman, Amit M Saindane, Nancy J Newman, et al.
Eye (London, England)|December 8, 2025
Infographic: GiACTA - Trial of Tocilizumab in Giant-Cell ArteritisOumar El-Aina, Gabriele Berman, Susan P Mollan, et al.
Eye (London, England)|October 15, 2025
Infographic: Landmark Trials in Neuro-Ophthalmology-Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical TrialAnika Rao, Michael Lowe, Alex Sinclair, et al.
Eye (London, England)|August 26, 2025
Infographic: Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset (RESCUE Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Neuro-Chirurgie|December 2, 2025
Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension"Georgios Tsermoulas, Nicholas Gikas, Alexandra J Sinclair, et al.
Eye (London, England)|October 14, 2025
Infographic: Landmark trials in Neuro-Ophthalmology -results of the randomised sequential cross-over trial evaluating five purportedly ICP lowering drugs in idiopathic intracranial hypertensionGabriele Berman, James L Mitchell, Michael Lowe, et al.
Eye (London, England)|March 30, 2026
Infographic: teprotumumab for the treatment of active thyroid eye diseaseErind Alushaj, Michael Lowe, Susan P Mollan, et al.
Eye (London, England)|July 16, 2025
Infographic: Landmark trials in Neuro-Ophthalmology-results of the phase II Idiopathic Intracranial Hypertension Pressure TrialGabriele Berman, Michael Lowe, Georgios Tsermoulas, et al.
Eye (London, England)|February 5, 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|September 18, 2025
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trialMichael Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 22, 2023
New Meningoencephalocele and Skull Base Changes Revealed by Trigeminal Neuralgia 14 Years After Diagnosis of Idiopathic Intracranial HypertensionGabriele Berman, Amit M Saindane, Nancy J Newman, et al.
Eye (London, England)|December 8, 2025
Infographic: GiACTA - Trial of Tocilizumab in Giant-Cell ArteritisOumar El-Aina, Gabriele Berman, Susan P Mollan, et al.
Eye (London, England)|October 15, 2025
Infographic: Landmark Trials in Neuro-Ophthalmology-Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical TrialAnika Rao, Michael Lowe, Alex Sinclair, et al.
Eye (London, England)|August 26, 2025
Infographic: Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset (RESCUE Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Neuro-Chirurgie|December 2, 2025
Comment on "Surgical versus endovascular treatment for idiopathic intracranial hypertension"Georgios Tsermoulas, Nicholas Gikas, Alexandra J Sinclair, et al.
Eye (London, England)|October 14, 2025
Infographic: Landmark trials in Neuro-Ophthalmology -results of the randomised sequential cross-over trial evaluating five purportedly ICP lowering drugs in idiopathic intracranial hypertensionGabriele Berman, James L Mitchell, Michael Lowe, et al.
Eye (London, England)|March 30, 2026
Infographic: teprotumumab for the treatment of active thyroid eye diseaseErind Alushaj, Michael Lowe, Susan P Mollan, et al.
Eye (London, England)|July 16, 2025
Infographic: Landmark trials in Neuro-Ophthalmology-results of the phase II Idiopathic Intracranial Hypertension Pressure TrialGabriele Berman, Michael Lowe, Georgios Tsermoulas, et al.
Eye (London, England)|February 5, 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|September 18, 2025
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trialMichael Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Pageof 4